Ried-Larsen Mathias, Thomsen Reimar W, Berencsi Klara, Brinkløv Cecilie F, Brøns Charlotte, Valentiner Laura S, Karstoft Kristian, Langberg Henning, Vaag Allan A, Pedersen Bente K, Nielsen Jens S
Department of Infectious Diseases, Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; The Danish Diabetes Academy, Odense University Hospital, Odense, Denmark; Department of Infectious Diseases, Centre of Inflammation and Metabolism, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
The Danish Diabetes Academy, Odense University Hospital, Odense, Denmark; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus Nord, Denmark.
Clin Epidemiol. 2016 Jun 8;8:201-9. doi: 10.2147/CLEP.S97303. eCollection 2016.
Promoting physical activity is a first-line choice of treatment for patients with type 2 diabetes (T2D). However, there is a need for more effective tools and technologies to facilitate structured lifestyle interventions and to ensure a better compliance, sustainability, and health benefits of exercise training in patients with T2D. The InterWalk initiative and its innovative application (app) for smartphones described in this study were developed by the Danish Centre for Strategic Research in T2D aiming at implementing, testing, and validating interval walking in patients with T2D in Denmark. The interval walking training approach consists of repetitive 3-minute cycles of slow and fast walking with simultaneous intensity guiding, based on the exercise capacity of the user. The individual intensity during slow and fast walking is determined by a short initial self-conducted and audio-guided fitness test, which combined with automated audio instructions strives to motivate the individual to adjust the intensity to the predetermined individualized walking intensities. The InterWalk app data are collected prospectively from all users and will be linked to the unique Danish nationwide databases and administrative registries, allowing extensive epidemiological studies of exercise in patients with T2D, such as the level of adherence to InterWalk training and long-term effectiveness surveys of important health outcomes, including cardiovascular morbidity and mortality. Currently, the InterWalk app has been downloaded by >30,000 persons, and the achieved epidemiological data quality is encouraging. Of the 9,466 persons providing personal information, 80% of the men and 62% women were overweight or obese (body mass index ≥25). The InterWalk project represents a contemporary technology-driven public health approach to monitor real-life exercise adherence and to propagate improved health through exercise intervention in T2D and in the general population.
促进身体活动是2型糖尿病(T2D)患者的一线治疗选择。然而,需要更有效的工具和技术来促进结构化的生活方式干预,并确保T2D患者运动训练有更好的依从性、可持续性和健康益处。本研究中描述的InterWalk倡议及其针对智能手机的创新应用程序(应用)由丹麦T2D战略研究中心开发,旨在在丹麦对T2D患者实施、测试和验证间歇步行。间歇步行训练方法包括基于用户运动能力的重复3分钟慢走和快走循环,并同时进行强度指导。慢走和快走期间的个体强度由简短的初始自我进行的音频引导体能测试确定,该测试与自动音频指令相结合,力求激励个体将强度调整到预定的个性化步行强度。InterWalk应用程序的数据是前瞻性地从所有用户收集的,并将与丹麦独特的全国性数据库和行政登记处相链接,从而能够对T2D患者的运动进行广泛的流行病学研究,例如对InterWalk训练的依从程度以及对包括心血管发病率和死亡率在内的重要健康结果的长期有效性调查。目前,InterWalk应用程序已被超过30000人下载,所获得的流行病学数据质量令人鼓舞。在提供个人信息的9466人中,80%的男性和62%的女性超重或肥胖(体重指数≥25)。InterWalk项目代表了一种当代技术驱动的公共卫生方法,用于监测现实生活中的运动依从性,并通过对T2D患者和普通人群进行运动干预来促进健康改善。